Emerging drugs for functional dyspepsia

The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man

(2010) E. Scarpellini et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Gastroduodenal Disorders

(2010) Jan Tack et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Functional Dyspepsia Impacts Absenteeism and Direct and Indirect Costs

(2010) Richard A. Brook et al.   Clinical Gastroenterology and Hepatology

Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study

(2010) N. Ejskjaer et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Acotiamide (Z-338) as a possible candidate for the treatment of functional dyspepsia

(2010) H. Suzuki et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage

(2010) K. Matsueda et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis

(2009) N. EJSKJAER et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy of the 5-HT1A Agonist Tandospirone Citrate in Improving Symptoms of Patients With Functional Dyspepsia: A Randomized Controlled Trial

(2009) Hiroto Miwa et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Long-Term Tegaserod Treatment for Dysmotility-like Functional Dyspepsia: Results of Two Identical 1-year Cohort Studies

(2009) William D. Chey et al.   DIGESTIVE DISEASES AND SCIENCES

235 PF-04548043, a Novel Motilin Receptor Agonist, Increases Gastric Emptying in Healthy Volunteers and Does Not Undergo Tachyphylaxis

(2009) Jeremy D. Gale et al.   GASTROENTEROLOGY

A placebo-controlled trial of the 5-HT1Aagonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia

(2009) j. tack et al.   NEUROGASTROENTEROLOGY AND MOTILITY

GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility

(2009) g. j. sanger et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Translating 5-HT4receptor pharmacology

(2009) g. j. sanger   NEUROGASTROENTEROLOGY AND MOTILITY

Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings

(2009) h. piessevaux et al.   NEUROGASTROENTEROLOGY AND MOTILITY

A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia

(2009) j. tack et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Japanese herbal medicine in functional gastrointestinal disorders

(2009) h. suzuki et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Prucalopride: a new drug for the treatment of chronic constipation

(2009) Jan Tack   Expert Review of Gastroenterology & Hepatology

Influence of buspirone on gastric sensorimotor function in man

(2008) L. VAN OUDENHOVE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: a randomized controlled cross-over study of flupenthixol + melitracen in functional dyspepsia

(2008) J. G. HASHASH et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia

(2008) N. J. TALLEY et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effect of the Antidepressant Venlafaxine in Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) L VANKERKHOVEN et al.   Clinical Gastroenterology and Hepatology

Prokinetics and fundic relaxants in upper functional GI disorders

(2008) J TACK   CURRENT OPINION IN PHARMACOLOGY

This Month in Gastroenterology

(2008) Jan Tack et al.   GASTROENTEROLOGY

Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats

(2008) k. seto et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia?

(2008) Lukas Van Oudenhove et al.   Nature clinical practice. Gastroenterology & hepatology

Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

(2007) N J Talley et al.   GUT